IL250530B - Production of functional and fully processed factor x in a mammalian purine-secreting expression system - Google Patents

Production of functional and fully processed factor x in a mammalian purine-secreting expression system

Info

Publication number
IL250530B
IL250530B IL250530A IL25053017A IL250530B IL 250530 B IL250530 B IL 250530B IL 250530 A IL250530 A IL 250530A IL 25053017 A IL25053017 A IL 25053017A IL 250530 B IL250530 B IL 250530B
Authority
IL
Israel
Prior art keywords
furin
production
expression system
mammalian expression
fully processed
Prior art date
Application number
IL250530A
Other languages
English (en)
Hebrew (he)
Other versions
IL250530A0 (en
Original Assignee
Baxalta Inc
Baxalta GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxalta Inc, Baxalta GmbH filed Critical Baxalta Inc
Publication of IL250530A0 publication Critical patent/IL250530A0/en
Publication of IL250530B publication Critical patent/IL250530B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6432—Coagulation factor Xa (3.4.21.6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6454—Dibasic site splicing serine proteases, e.g. kexin (3.4.21.61); furin (3.4.21.75) and other proprotein convertases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21006—Coagulation factor Xa (3.4.21.6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21075—Furin (3.4.21.75)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL250530A 2014-08-12 2017-02-09 Production of functional and fully processed factor x in a mammalian purine-secreting expression system IL250530B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462036438P 2014-08-12 2014-08-12
PCT/US2015/044883 WO2016025615A1 (en) 2014-08-12 2015-08-12 Production of fully processed and functional factor x in a furin-secreting mammalian expression system

Publications (2)

Publication Number Publication Date
IL250530A0 IL250530A0 (en) 2017-03-30
IL250530B true IL250530B (en) 2020-03-31

Family

ID=54035298

Family Applications (1)

Application Number Title Priority Date Filing Date
IL250530A IL250530B (en) 2014-08-12 2017-02-09 Production of functional and fully processed factor x in a mammalian purine-secreting expression system

Country Status (14)

Country Link
US (1) US9873892B2 (OSRAM)
EP (1) EP3180427B1 (OSRAM)
JP (1) JP6793114B2 (OSRAM)
CN (1) CN107002041B (OSRAM)
AR (1) AR102048A1 (OSRAM)
AU (1) AU2015301726B2 (OSRAM)
CA (1) CA2958056C (OSRAM)
EA (1) EA035444B1 (OSRAM)
ES (1) ES2742724T3 (OSRAM)
IL (1) IL250530B (OSRAM)
MX (1) MX377236B (OSRAM)
NZ (1) NZ729729A (OSRAM)
TW (1) TWI666319B (OSRAM)
WO (1) WO2016025615A1 (OSRAM)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8241623B1 (en) 2009-02-09 2012-08-14 David Bermudes Protease sensitivity expression system
US11299533B2 (en) 2017-06-23 2022-04-12 Takeda Pharmaceutical Company Limited Purification of factor VIII subspecies
WO2020257942A1 (en) * 2019-06-28 2020-12-30 Peel Sean A F A method for increasing yields and the specific activity of certain recombinant proteins in mammalian cells by co-expressing full-length furin
GB202018320D0 (en) * 2020-11-20 2021-01-06 Univ Newcastle Methods of producing recombinant complement proteins
WO2023141754A1 (zh) * 2022-01-25 2023-08-03 青岛万明赛伯药业有限公司 proNGF突变体及其用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0574402B2 (en) 1990-11-26 2012-08-01 Genetics Institute, LLC Expression of pace in host cells and methods of use thereof
AT404838B (de) * 1995-11-24 1999-03-25 Immuno Ag Herstellung von proteinen aus pro-proteinen durch fusionsproteine abgeleitet von furin oder furinanalogen
JPH09295945A (ja) * 1996-04-30 1997-11-18 Hoechst Yakuhin Kogyo Kk 成熟型骨誘導因子の製造方法
US5876923A (en) 1996-07-26 1999-03-02 Arch Development Corporation Herpes simplex virus ICP4 as an inhibitor of apoptosis
AU784195B2 (en) 1999-11-12 2006-02-16 Baxter Biotech Technology S.A.R.L. Reduced side-effect hemoglobin compositions
US6596526B1 (en) * 2000-06-09 2003-07-22 Baxter Aktiengesellschaft Furin polypeptides with improved characteristics
US7223390B2 (en) * 2003-05-09 2007-05-29 Research Development Foundation Insertion of furin protease cleavage sites in membrane proteins and uses thereof
EP1969127B8 (en) * 2005-12-21 2017-12-13 Aptevo BioTherapeutics LLC Method of producing biologically active vitamin k dependent proteins by recombinant methods
KR101156263B1 (ko) 2007-05-18 2012-06-13 박스터 헬쓰케어 에스.에이. 폰 빌리브란트 인자 프로펩티드로부터 성숙한 폰 빌리브란트 인자를 제조하는 방법
WO2009088713A1 (en) * 2007-12-31 2009-07-16 Baxter International Inc. Substantially animal protein-free recombinant furin and methods for producing same
JP5843357B2 (ja) 2009-02-03 2016-01-13 アムニクス オペレーティング インコーポレイテッド 延長組換えポリペプチドおよび延長組換えポリペプチドを含む組成物
CA2837948C (en) 2011-06-02 2018-08-21 Baxter International Inc. Formulations of recombinant furin

Also Published As

Publication number Publication date
CN107002041B (zh) 2021-06-29
AU2015301726A1 (en) 2017-03-16
EA035444B1 (ru) 2020-06-17
US9873892B2 (en) 2018-01-23
JP2017524366A (ja) 2017-08-31
MX377236B (es) 2025-03-07
EP3180427A1 (en) 2017-06-21
CA2958056A1 (en) 2016-02-18
NZ729729A (en) 2023-07-28
MX2017001931A (es) 2017-06-30
CN107002041A (zh) 2017-08-01
AR102048A1 (es) 2017-02-01
EP3180427B1 (en) 2019-05-22
IL250530A0 (en) 2017-03-30
WO2016025615A1 (en) 2016-02-18
TW201625791A (zh) 2016-07-16
US20160046957A1 (en) 2016-02-18
TWI666319B (zh) 2019-07-21
CA2958056C (en) 2023-07-04
EA201790360A1 (ru) 2017-06-30
AU2015301726B2 (en) 2021-10-21
ES2742724T3 (es) 2020-02-17
JP6793114B2 (ja) 2020-12-09

Similar Documents

Publication Publication Date Title
IL247963A0 (en) Solid forms of ibrutinib and process for their preparation
ZA201608040B (en) Capacitor and method of production thereof
SG11201606575TA (en) Method of producing polyethylene and polyethylene thereof
HUE046384T2 (hu) Gyártóberendezés és gyártási eljárás
SG11201607256PA (en) Deposition system with multi-cathode and method of manufacture thereof
HUE047226T2 (hu) Formatest és eljárás annak az elõállítására
PL3177900T3 (pl) Czujniki i sposób wytwarzania czujników
GB201309173D0 (en) Novel process and product
GB2542967B (en) Improvements to halocarbon recycling methods and systems
EP3120984A4 (en) Fiber-reinforced plastic and production method therefor
LU92409B1 (en) Means and methods for itaconic acid production
EP3008995A4 (en) CULTIVATION ORGANISM GROWING METHOD, AND CULTIVATION PLANT
TWI562034B (en) Touch panel and manufacture method thereof
GB201301639D0 (en) Product and process
GB201414210D0 (en) Bulk culture system and method
GB201420309D0 (en) Elctrode Structure and method of manufacture thereof
PT3192821T (pt) Partículas de poliolefina modificada e processo para a sua produção
EP3234167C0 (en) CHITIN AND CHITOSAN PRODUCTION PROCESSES
IL250530A0 (en) Production of functional and fully processed factor x in a mammalian purine-secreting expression system
GB201417268D0 (en) Modified microorganisms and methods for production of useful products
GB201706879D0 (en) Article of luggage and method of assembling
PT3146058T (pt) Processo de fermentação para a produção e controlo de produtos derivados de piruvato
SG11201610514SA (en) Bioreactor and uses thereof
EP3132920A4 (en) Three-dimensional shaped article production method and three-dimensional shaped article
EP3085819A4 (en) Fabric production method and fabric

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed